Review MASLD/SLD impact, NITs for risk stratification, lifestyle/medication management, current MASH therapies, and global/US consensus recommendations for MASH by gastroenterology providers and APPs.
Enhance your expertise in MASH diagnosis and management with this one-of-a-kind preceptorship. Join us for a two-part training experience designed to elevate your skills—both in foundational learning and in-clinic shadowing. Apply today!
This course focuses on strategies, healthcare business trends, literature, and testimonials on the change of NP and PA utilization in leadership, education, research, innovation, and professional development. Group discounts available.
The accredited preceptorship includes two primary phases: foundational training and in-clinic workshops.
FASENRA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma, and with an eosinophilic phenotype. FASENRA is not for the relief of acute bronchospasm or status asthmaticus.
This is a one-day in-person CE conference for pediatric-focused APPs. Vendor-hosted breakfast and lunch are included. The conference will include a full day of educational topics, networking, student poster presentations and a vendor hall.